These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38890325)

  • 1. Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin.
    Lei R; Liang W; Ouyang WO; Hernandez Garcia A; Kikuchi C; Wang S; McBride R; Tan TJC; Sun Y; Chen C; Graham CS; Rodriguez LA; Shen IR; Choi D; Bruzzone R; Paulson JC; Nair SK; Mok CKP; Wu NC
    Nat Commun; 2024 Jun; 15(1):5175. PubMed ID: 38890325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A complex epistatic network limits the mutational reversibility in the influenza hemagglutinin receptor-binding site.
    Wu NC; Thompson AJ; Xie J; Lin CW; Nycholat CM; Zhu X; Lerner RA; Paulson JC; Wilson IA
    Nat Commun; 2018 Mar; 9(1):1264. PubMed ID: 29593268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins.
    Yang H; Carney PJ; Chang JC; Guo Z; Villanueva JM; Stevens J
    Virology; 2015 Mar; 477():18-31. PubMed ID: 25617824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H3N2 Influenza Viruses with 12- or 16-Amino Acid Deletions in the Receptor-Binding Region of Their Hemagglutinin Protein.
    Kong H; Fan S; Takada K; Imai M; Neumann G; Kawaoka Y
    mBio; 2021 Dec; 12(6):e0151221. PubMed ID: 34872354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of Functionally Permissive Sequences in the Receptor-Binding Site of Influenza Hemagglutinin.
    Wu NC; Xie J; Zheng T; Nycholat CM; Grande G; Paulson JC; Lerner RA; Wilson IA
    Cell Host Microbe; 2017 Jun; 21(6):742-753.e8. PubMed ID: 28618270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility.
    Wu NC; Lv H; Thompson AJ; Wu DC; Ng WWS; Kadam RU; Lin CW; Nycholat CM; McBride R; Liang W; Paulson JC; Mok CKP; Wilson IA
    Cell Host Microbe; 2019 Jun; 25(6):836-844.e5. PubMed ID: 31151913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycan-binding preferences and genetic evolution of human seasonal influenza A(H3N2) viruses during 1999-2007 in Taiwan.
    Wang YF; Chang CF; Tsai HP; Chi CY; Su IJ; Wang JR
    PLoS One; 2018; 13(5):e0196727. PubMed ID: 29746492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major antigenic site B of human influenza H3N2 viruses has an evolving local fitness landscape.
    Wu NC; Otwinowski J; Thompson AJ; Nycholat CM; Nourmohammad A; Wilson IA
    Nat Commun; 2020 Mar; 11(1):1233. PubMed ID: 32144244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin.
    Lin YP; Xiong X; Wharton SA; Martin SR; Coombs PJ; Vachieri SG; Christodoulou E; Walker PA; Liu J; Skehel JJ; Gamblin SJ; Hay AJ; Daniels RS; McCauley JW
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21474-9. PubMed ID: 23236176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural significance of residues 158-160 in the H3N2 hemagglutnin globular head: A computational study with implications in viral evolution and infection.
    Cueno ME; Shiotsu H; Nakano K; Sugiyama E; Kikuta M; Usui R; Oya R; Imai K
    J Mol Graph Model; 2019 Jun; 89():33-40. PubMed ID: 30849718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insights into evolution, mutations and receptor-binding specificity of influenza A and B viruses from outpatients and hospitalized patients in Singapore.
    Ivan FX; Zhou X; Lau SH; Rashid S; Teo JSM; Lee HK; Koay ES; Chan KP; Leo YS; Chen MIC; Kwoh CK; Chow VT
    Int J Infect Dis; 2020 Jan; 90():84-96. PubMed ID: 31669593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation and Epistasis in Influenza Virus Evolution.
    Lyons DM; Lauring AS
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30081492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany.
    Wedde M; Biere B; Wolff T; Schweiger B
    Int J Med Microbiol; 2015 Oct; 305(7):762-75. PubMed ID: 26416089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Egg-adaptive mutations of human influenza H3N2 virus are contingent on natural evolution.
    Liang W; Tan TJC; Wang Y; Lv H; Sun Y; Bruzzone R; Mok CKP; Wu NC
    PLoS Pathog; 2022 Sep; 18(9):e1010875. PubMed ID: 36155668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino Acids in Hemagglutinin Antigenic Site B Determine Antigenic and Receptor Binding Differences between A(H3N2)v and Ancestral Seasonal H3N2 Influenza Viruses.
    Wang X; Ilyushina NA; Lugovtsev VY; Bovin NV; Couzens LK; Gao J; Donnelly RP; Eichelberger MC; Wan H
    J Virol; 2017 Jan; 91(2):. PubMed ID: 27807224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of human H3N2 influenza virus receptor specificity has substantially expanded the receptor-binding domain site.
    Thompson AJ; Wu NC; Canales A; Kikuchi C; Zhu X; de Toro BF; Cañada FJ; Worth C; Wang S; McBride R; Peng W; Nycholat CM; Jiménez-Barbero J; Wilson IA; Paulson JC
    Cell Host Microbe; 2024 Feb; 32(2):261-275.e4. PubMed ID: 38307019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.
    Li Y; Bostick DL; Sullivan CB; Myers JL; Griesemer SB; Stgeorge K; Plotkin JB; Hensley SE
    J Virol; 2013 Sep; 87(17):9904-10. PubMed ID: 23824816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Human-Type Receptor Binding by Ferret-Transmissible H5N1 with a K193T Mutation.
    Peng W; Bouwman KM; McBride R; Grant OC; Woods RJ; Verheije MH; Paulson JC; de Vries RP
    J Virol; 2018 May; 92(10):. PubMed ID: 29491160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine.
    Lewis NS; Anderson TK; Kitikoon P; Skepner E; Burke DF; Vincent AL
    J Virol; 2014 May; 88(9):4752-63. PubMed ID: 24522915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.